| Christy Lynn Hobby, OT | |
|
1300 W Rosedale St, Suite A, Fort Worth, TX 76104-2826 | |
| (817) 377-4011 | |
| (817) 377-9269 |
| Full Name | Christy Lynn Hobby |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1300 W Rosedale St, Fort Worth, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023439049 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 105516 (Texas) | Primary |
| Provider Name | A Medical Advantage Healthcare Systems Associated |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1477505592 PECOS PAC ID: 8123009677 Enrollment ID: O20090416000357 |
News Archive
AstraZeneca today announced plans to conduct the EUCLID study, a global clinical trial involving 11,500 patients with peripheral artery disease (PAD), a condition affecting approximately 27 million people in Europe and North America.
Two thirds of individuals 65 and older who screened positive for cognitive impairment refused subsequent evaluation according to the first study of its kind to examine older adults' willingness to undergo diagnostic assessment. The Indiana University Center for Aging Research, Regenstrief Institute and Eskenazi Health study of approximately 500 older adults found that individuals living alone were the least likely to agree to diagnostic assessment following a positive screening test for dementia.
The Center for American Progress proposals thus wisely recognize that there is no single strategy to continue the recent progress in slowing the growth in health-care costs. In contrast, the Republican budget plan put forward by Representative Paul Ryan of Wisconsin seems based on a belief that all that's needed is to shift risks: from Medicare to beneficiaries through a premium-support program, and from the federal government to state governments by turning Medicaid into block grants.
In a study to be published in the April, 2006 issue of the British Journal of Urology International, researchers at Cedars-Sinai Medical Center have shown that Raloxifene, a drug commonly used to treat osteoporosis, has a potential clinical benefit in treating men with prostate cancer.
Bederra Corporation, a Houston, Texas based diversified medical services provider, announced that the company has signed a Letter of Intent to acquire Texas Mobile Health, Inc.
› Verified 8 days ago
| Provider Name | Rehabilitation Physicians Network Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1508095761 PECOS PAC ID: 3476725227 Enrollment ID: O20111020000456 |
News Archive
AstraZeneca today announced plans to conduct the EUCLID study, a global clinical trial involving 11,500 patients with peripheral artery disease (PAD), a condition affecting approximately 27 million people in Europe and North America.
Two thirds of individuals 65 and older who screened positive for cognitive impairment refused subsequent evaluation according to the first study of its kind to examine older adults' willingness to undergo diagnostic assessment. The Indiana University Center for Aging Research, Regenstrief Institute and Eskenazi Health study of approximately 500 older adults found that individuals living alone were the least likely to agree to diagnostic assessment following a positive screening test for dementia.
The Center for American Progress proposals thus wisely recognize that there is no single strategy to continue the recent progress in slowing the growth in health-care costs. In contrast, the Republican budget plan put forward by Representative Paul Ryan of Wisconsin seems based on a belief that all that's needed is to shift risks: from Medicare to beneficiaries through a premium-support program, and from the federal government to state governments by turning Medicaid into block grants.
In a study to be published in the April, 2006 issue of the British Journal of Urology International, researchers at Cedars-Sinai Medical Center have shown that Raloxifene, a drug commonly used to treat osteoporosis, has a potential clinical benefit in treating men with prostate cancer.
Bederra Corporation, a Houston, Texas based diversified medical services provider, announced that the company has signed a Letter of Intent to acquire Texas Mobile Health, Inc.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christy Lynn Hobby, OT 1300 W Rosedale St, Suite A, Fort Worth, TX 76104-2826 Ph: (817) 377-4011 | Christy Lynn Hobby, OT 1300 W Rosedale St, Suite A, Fort Worth, TX 76104-2826 Ph: (817) 377-4011 |
News Archive
AstraZeneca today announced plans to conduct the EUCLID study, a global clinical trial involving 11,500 patients with peripheral artery disease (PAD), a condition affecting approximately 27 million people in Europe and North America.
Two thirds of individuals 65 and older who screened positive for cognitive impairment refused subsequent evaluation according to the first study of its kind to examine older adults' willingness to undergo diagnostic assessment. The Indiana University Center for Aging Research, Regenstrief Institute and Eskenazi Health study of approximately 500 older adults found that individuals living alone were the least likely to agree to diagnostic assessment following a positive screening test for dementia.
The Center for American Progress proposals thus wisely recognize that there is no single strategy to continue the recent progress in slowing the growth in health-care costs. In contrast, the Republican budget plan put forward by Representative Paul Ryan of Wisconsin seems based on a belief that all that's needed is to shift risks: from Medicare to beneficiaries through a premium-support program, and from the federal government to state governments by turning Medicaid into block grants.
In a study to be published in the April, 2006 issue of the British Journal of Urology International, researchers at Cedars-Sinai Medical Center have shown that Raloxifene, a drug commonly used to treat osteoporosis, has a potential clinical benefit in treating men with prostate cancer.
Bederra Corporation, a Houston, Texas based diversified medical services provider, announced that the company has signed a Letter of Intent to acquire Texas Mobile Health, Inc.
› Verified 8 days ago
Ms. Mary Cathrine Mckenzie, MOT/OTR, CPRCS Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7217 Hawkins View Dr Ste 201, Fort Worth, TX 76132 Phone: 817-479-7019 | |
Holly Christina Andrews, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5316 Trail Lake Dr, Fort Worth, TX 76133 Phone: 817-292-8787 Fax: 817-789-6489 | |
Mrs. Sue Khammar, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4140 Tamworth Rd, Fort Worth, TX 76116 Phone: 817-386-5500 Fax: 817-386-5500 | |
Danyelle Braelyn Huffaker, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 8000 Calmont Ave, Fort Worth, TX 76116 Phone: 817-400-2273 | |
Lauren Elizabeth Galipp, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3840 Hulen St, Fort Worth, TX 76107 Phone: 817-335-3022 | |
Katherine Moos, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5300 Altamesa Blvd, Fort Worth, TX 76133 Phone: 817-346-1800 | |
Diane R Alfino, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2500 West Fwy, Suite 100, Fort Worth, TX 76102 Phone: 888-997-2669 |